Nizatidine

CHEMBL3183075 Phase 4 معتمد Small molecule

Half-Life

—

Bioavailability

—

Protein Binding

—

Molecular Weight

331.5 g/mol

LogP

1.6

Phase

4

An H2 blocker that reduces stomach acid production to help heal ulcers and relieve heartburn.

الوزن الجزيئي

331,5000 g/mol

LogP

1,60

TPSA

140,00 Å²

قاعدة ليبينسكي للخمسة

ناجح

المجالات العلاجية

Schizophrenia Gastroesophageal Reflux Disease

Pharmacokinetics (PK)

Pharmacodynamics (PD)

البنية ثنائية الأبعاد

SVG PNG

Cite this structure

Embed this structure

SMILES

CNC(=C[N+](=O)[O-])NCCSCc1csc(CN(C)C)n1

InChI

InChI=1S/C12H21N5O2S2/c1-13-11(6-17(18)19)14-4-5-20-8-10-9-21-12(15-10)7-16(2)3/h6,9,13-14H,4-5,7-8H2,1-3H3

Molecular Formula

C12H21N5O2S2

HBD / HBA

2 / 8

الروابط القابلة للدوران

9

الذرات الثقيلة

21

No targets recorded

Target interaction data is not yet available for this drug.

No interactions recorded

Drug interaction data is not yet available for this compound.

No side effects recorded

Side effect data is not yet available for this drug.

الأسئلة الشائعة

An H2 blocker that reduces stomach acid production to help heal ulcers and relieve heartburn.

Yes, Nizatidine is an approved drug. It has reached clinical phase 4. It is classified as a Small molecule.

{# References & Data Sources section for drug detail pages. Renders standard pharmacological database links plus the drug's data_sources field. #}

References & Data Sources

ChEMBL — European Bioinformatics Institute (EBI). CHEMBL3183075. Open-access bioactivity database.
PubChem — National Center for Biotechnology Information (NCBI). CID 4513. Chemical information database.

Data aggregated from publicly available pharmacological databases. Last updated 2026-03-28.

PillFYI

هل تبحث عن معلومات ملائمة للمرضى؟

Nizatidine على PillFYI

البنية

بيانات سريعة

الصيغة الجزيئية: C12H21N5O2S2

روابط خارجية

Cite

BibTeX, APA, MLA, Chicago, IEEE, Harvard

إخلاء المسؤولية الطبية

This content is for educational and informational purposes only. It is not a substitute for professional medical advice, diagnosis, or treatment. Always consult a qualified healthcare provider before making medication decisions.

Data sources: ChEMBL, PubChem, DailyMed.